FibroGen Inc
NASDAQ:KYNB
FibroGen Inc
NASDAQ:KYNB
Price:
7.39
USD
2.5%
Market Closed
Market Cap:
$29.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
FibroGen Inc
NASDAQ:KYNB
|
US |
|
M
|
Medifast Inc
SWB:MDF
|
US |
Wall St Price Targets
KYNB Price Targets Summary
FibroGen Inc
FibroGen Inc
Wall Street analysts forecast KYNB stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for KYNB is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.
Lowest Forecast
Price Target
43.43
USD
488% Upside
Average Forecast
Price Target
43.86
USD
494% Upside
Highest Forecast
Price Target
45.15
USD
511% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KYNB's stock price target?
Price Target
43.86
USD
43.86
USD
According to Wall Street analysts, the average 1-year price target for KYNB is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.
What is the Revenue forecast for FibroGen Inc?
Projected CAGR
-32%
-32%
Over the last 11 years, the compound annual growth rate for Revenue has been -11%. The projected CAGR for the next 4 years is -32%.
